Indian drug maker Sun Pharmaceutical on Monday surged as much as 3 per cent in morning trade on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) amid news that the company is likely to enter into a marketing tie up with US drug major Merck & Co.
Shares of Sun Pharma touched Rs 455.90, a jump of 3 per cent over its previous closing price on the
BSE. A similar trend was witnessed in NSE where the scrip surged by 3 per cent to Rs 454.90 a piece.
The partnership, if announced, would be the second such large scale sales and marketing tie up between a multinational and local drug maker this year after German drug firm Bayer AG announced a joint marketing venture with Ahmedabad-based Cadila Healthcare in January.
Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Special 
